Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nat Commun ; 15(1): 5282, 2024 Jun 20.
Artigo em Inglês | MEDLINE | ID: mdl-38902255

RESUMO

During pulmonary mucormycosis, inhaled sporangiospores adhere to, germinate, and invade airway epithelial cells to establish infection. We provide evidence that HIF1α plays dual roles in airway epithelial cells during Mucorales infection. We observed an increase in HIF1α protein accumulation and increased expression of many known HIF1α-responsive genes during in vitro infection, indicating that HIF1α signaling is activated by Mucorales infection. Inhibition of HIF1α signaling led to a substantial decrease in the ability of R. delemar to invade cultured airway epithelial cells. Transcriptome analysis revealed that R. delemar infection induces the expression of many pro-inflammatory genes whose expression was significantly reduced by HIF1α inhibition. Importantly, pharmacological inhibition of HIF1α increased survival in a mouse model of pulmonary mucormycosis without reducing fungal burden. These results suggest that HIF1α plays two opposing roles during mucormycosis: one that facilitates the ability of Mucorales to invade the host cells and one that facilitates the ability of the host to mount an innate immune response.


Assuntos
Células Epiteliais , Subunidade alfa do Fator 1 Induzível por Hipóxia , Mucorales , Mucormicose , Animais , Feminino , Humanos , Camundongos , Modelos Animais de Doenças , Células Epiteliais/metabolismo , Células Epiteliais/microbiologia , Perfilação da Expressão Gênica , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Subunidade alfa do Fator 1 Induzível por Hipóxia/genética , Pulmão/microbiologia , Pulmão/imunologia , Pulmão/metabolismo , Pulmão/patologia , Camundongos Endogâmicos C57BL , Mucorales/metabolismo , Mucorales/genética , Mucormicose/microbiologia , Mucormicose/metabolismo , Mucormicose/imunologia , Transdução de Sinais
2.
mBio ; 12(6): e0300021, 2021 12 21.
Artigo em Inglês | MEDLINE | ID: mdl-34809463

RESUMO

Calcineurin is a critical enzyme in fungal pathogenesis and antifungal drug tolerance and, therefore, an attractive antifungal target. Current clinically accessible calcineurin inhibitors, such as FK506, are immunosuppressive to humans, so exploiting calcineurin inhibition as an antifungal strategy necessitates fungal specificity in order to avoid inhibiting the human pathway. Harnessing fungal calcineurin-inhibitor crystal structures, we recently developed a less immunosuppressive FK506 analog, APX879, with broad-spectrum antifungal activity and demonstrable efficacy in a murine model of invasive fungal infection. Our overarching goal is to better understand, at a molecular level, the interaction determinants of the human and fungal FK506-binding proteins (FKBP12) required for calcineurin inhibition in order to guide the design of fungus-selective, nonimmunosuppressive FK506 analogs. To this end, we characterized high-resolution structures of the Mucor circinelloides FKBP12 bound to FK506 and of the Aspergillus fumigatus, M. circinelloides, and human FKBP12 proteins bound to the FK506 analog APX879, which exhibits enhanced selectivity for fungal pathogens. Combining structural, genetic, and biophysical methodologies with molecular dynamics simulations, we identify critical variations in these structurally similar FKBP12-ligand complexes. The work presented here, aimed at the rational design of more effective calcineurin inhibitors, indeed suggests that modifications to the APX879 scaffold centered around the C15, C16, C18, C36, and C37 positions provide the potential to significantly enhance fungal selectivity. IMPORTANCE Invasive fungal infections are a leading cause of death in the immunocompromised patient population. The rise in drug resistance to current antifungals highlights the urgent need to develop more efficacious and highly selective agents. Numerous investigations of major fungal pathogens have confirmed the critical role of the calcineurin pathway for fungal virulence, making it an attractive target for antifungal development. Although FK506 inhibits calcineurin, it is immunosuppressive in humans and cannot be used as an antifungal. By combining structural, genetic, biophysical, and in silico methodologies, we pinpoint regions of the FK506 scaffold and a less immunosuppressive analog, APX879, centered around the C15 to C18 and C36 to C37 positions that could be altered with selective extensions and/or deletions to enhance fungal selectivity. This work represents a significant advancement toward realizing calcineurin as a viable target for antifungal drug discovery.


Assuntos
Antifúngicos/química , Inibidores de Calcineurina/química , Calcineurina/química , Proteínas Fúngicas/química , Mucor/metabolismo , Mucormicose/microbiologia , Tacrolimo/química , Sequência de Aminoácidos , Antifúngicos/farmacologia , Calcineurina/genética , Calcineurina/metabolismo , Inibidores de Calcineurina/farmacologia , Desenho de Fármacos , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Interações Hospedeiro-Patógeno , Humanos , Mucor/efeitos dos fármacos , Mucor/genética , Mucormicose/tratamento farmacológico , Mucormicose/genética , Mucormicose/metabolismo , Alinhamento de Sequência , Tacrolimo/farmacologia , Proteína 1A de Ligação a Tacrolimo/química , Proteína 1A de Ligação a Tacrolimo/genética , Proteína 1A de Ligação a Tacrolimo/metabolismo
4.
Int J Biol Macromol ; 187: 988-998, 2021 Sep 30.
Artigo em Inglês | MEDLINE | ID: mdl-34324905

RESUMO

Mucormycosis is a deadly infection which is caused by fungi of the order Mucorales including species belonging to the genus Rhizopus, Mucor, Mycocladus, Rhizomucor, Cunninghamella, and Apophysomyces. Despite antifungal therapy and surgical procedures, the mortality rate of this disease is about 90-100% which is exceptionally high. The hypersensitivity of patients with raised available serum iron indicates that the Mucorales are able to use host iron as a critical factor of virulence. This is because iron happens to be a crucial element playing its role in the growth of cells and development. In this review, we have described Lactoferrin (Lf) as a potential iron-chelator. Lf is a naturally occurring glycoprotein which is expressed in most of the biological fluids. Moreover, Lf possesses exclusive anti-inflammatory effects along with several anti-fungal effects that could prove to be helpful to the pathological physiology of inexorable mucormycosis cases. This literature summarises the biological insights into the Lf being considered as a potential fungistatic agent and an immune regulator. The review also proposes that unique potential of Lf as an iron-chelator can be exploited as the adjunct treatment for mucormycosis infection.


Assuntos
Antifúngicos/uso terapêutico , Quelantes de Ferro/uso terapêutico , Ferro/metabolismo , Lactoferrina/uso terapêutico , Mucorales/efeitos dos fármacos , Mucormicose/tratamento farmacológico , Animais , Antifúngicos/efeitos adversos , Interações Hospedeiro-Patógeno , Humanos , Quelantes de Ferro/efeitos adversos , Lactoferrina/efeitos adversos , Mucorales/metabolismo , Mucorales/patogenicidade , Mucormicose/diagnóstico , Mucormicose/metabolismo , Mucormicose/microbiologia , Valor Preditivo dos Testes , Fatores de Risco
6.
Med Mycol ; 59(5): 505-509, 2021 May 04.
Artigo em Inglês | MEDLINE | ID: mdl-33336238

RESUMO

Activation of mucosal-associated invariant T cells (MAIT cells) by certain bacteria, viruses, and yeast is well studied, but the activation potential of filamentous moulds from the order Mucorales is not known. Here, we show a rapid response of human MAIT cells against the Mucorales species Mucor circinelloides, Rhizopus arrhizus, and Rhizopus microsporus. This activation included upregulation of CD69 and degranulation marked by increased CD107a expression, while intracellular perforin and granzyme A expression were reduced. Furthermore, blocking of the antigen-presenting molecule major histocompatibility complex class I-related abrogated MAIT cell activation demonstrating a T cell receptor-dependent stimulation by Mucorales.


Assuntos
Antígenos de Histocompatibilidade Classe I/metabolismo , Antígenos de Histocompatibilidade Menor/metabolismo , Mucorales/imunologia , Mucormicose/imunologia , Mucormicose/metabolismo , Células T Invariantes Associadas à Mucosa/imunologia , Células T Invariantes Associadas à Mucosa/metabolismo , Riboflavina/metabolismo , Antígenos CD/metabolismo , Antígenos de Diferenciação de Linfócitos T/metabolismo , Granzimas/metabolismo , Interações entre Hospedeiro e Microrganismos , Humanos , Lectinas Tipo C/metabolismo , Ativação Linfocitária , Proteína 1 de Membrana Associada ao Lisossomo/metabolismo , Mucor/imunologia , Mucormicose/microbiologia , Perforina/metabolismo , Rhizopus/imunologia , Rhizopus oryzae/imunologia , Regulação para Cima
7.
Genes (Basel) ; 11(11)2020 10 30.
Artigo em Inglês | MEDLINE | ID: mdl-33143139

RESUMO

Iron is a key transition metal required by most microorganisms and is prominently utilised in the transfer of electrons during metabolic reactions. The acquisition of iron is essential and becomes a crucial pathogenic event for opportunistic fungi. Iron is not readily available in the natural environment as it exists in its insoluble ferric form, i.e., in oxides and hydroxides. During infection, the host iron is bound to proteins such as transferrin, ferritin, and haemoglobin. As such, access to iron is one of the major hurdles that fungal pathogens must overcome in an immunocompromised host. Thus, these opportunistic fungi utilise three major iron acquisition systems to overcome this limiting factor for growth and proliferation. To date, numerous iron acquisition pathways have been fully characterised, with key components of these systems having major roles in virulence. Most recently, proteins involved in these pathways have been linked to the development of antifungal resistance. Here, we provide a detailed review of our current knowledge of iron acquisition in opportunistic fungi, and the role iron may have on the development of resistance to antifungals with emphasis on species of the fungal basal lineage order Mucorales, the causative agents of mucormycosis.


Assuntos
Ferro/metabolismo , Mucormicose/metabolismo , Micoses/metabolismo , Animais , Antifúngicos/farmacologia , Farmacorresistência Fúngica/genética , Farmacorresistência Fúngica/fisiologia , Humanos , Mucorales/genética , Mucorales/metabolismo , Mucormicose/tratamento farmacológico , Micoses/fisiopatologia , Infecções Oportunistas/metabolismo , Virulência
9.
Med Mycol ; 56(5): 631-644, 2018 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-29420826

RESUMO

Mucormycosis is one of the most invasive mycosis and has caused global concern in public health. Cutaneous mucormycosis caused by Mucor irregularis (formerly Rhizomucor variabilis) is an emerging disease in China. To survive in the human body, M. irregularis must overcome the hypoxic (low oxygen) host microenvironment. However, the exact molecular mechanism of its pathogenicity and adaptation to low oxygen stress environment is relatively unexplored. In this study, we used Illumina HiSeq technology (RNA-Seq) to determine and compare the transcriptome profile of M. irregularis CBS103.93 under normal growth condition and hypoxic stress. Our analyses demonstrated a series of genes involved in TCA, glyoxylate cycle, pentose phosphate pathway, and GABA shunt were down-regulated under hypoxic condition, while certain genes in the lipid/fatty acid metabolism and endocytosis were up-regulated, indicating that lipid metabolism was more active under hypoxia. Comparing the data with other important human pathogenic fungi such as Aspergillus spp., we found that the gene expression pattern and metabolism in responses to hypoxia in M. irregularis were unique and different. We proposed that these metabolic changes can represent a species-specific hypoxic adaptation in M. irregularis, and we hypothesized that M. irregularis could use the intra-lipid pool and lipid secreted in the infection region, as an extracellular nutrient source to support its hypoxic growth. Characterizing the significant differential gene expression in this species could be beneficial to uncover their role in hypoxia adaptation and fungalpathogenesis and further facilitate the development of novel targets in disease diagnosis and treatment against mucormycosis.


Assuntos
Dermatomicoses/microbiologia , Regulação Fúngica da Expressão Gênica , Mucor/genética , Mucor/metabolismo , Oxigênio/metabolismo , Transcriptoma , Adaptação Fisiológica , Carbono/metabolismo , Dermatomicoses/metabolismo , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Genes Fúngicos/genética , Humanos , Metabolismo dos Lipídeos , Redes e Vias Metabólicas/genética , Mucor/crescimento & desenvolvimento , Mucormicose/metabolismo , Mucormicose/microbiologia , RNA Mensageiro/genética , Reprodutibilidade dos Testes
10.
Mycopathologia ; 182(11-12): 1005-1014, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28685375

RESUMO

Metabolic control improves outcomes associated with mucormycosis. The aim of this study was to compare the in vitro proliferation of Rhizopus oryzae in blood of individuals with and without diabetes at different glycaemic levels. Ninety-five individuals were included. Blood samples from each participant were incubated with sporangiospores of R. oryzae. The germination, filamentation and growth of R. oryzae were compared at different time points. Four groups were defined, one without (group A, n = 30) and three with diabetes: group B (HbA1c ≤7%, N = 24), group C (HbA1c 7.1-9%, N = 20) and group D (HbA1c > 9%, N = 21). The percentage of germinated sporangiospores was higher in the group A after 6 h (group A 56% ± 3, group B 35% ± 4, group C 48% ± 4, group D 46% ± 1.4, p = 0.01), 12 h (group A 54% ± 1.4, group B 19% ± 4, group C 16% ± 1, group D 9.5% ± 5, p < 0.001) and 24 h (group A 29% ± 1, group B 12% ± 4, group C 13.5% ± 3.5, group D 12% ± 1, p < 0.01). The filamentation was higher in groups with diabetes. Group B showed higher filamentation grade than group A at 6 h (0.4 ± 0.04 vs 1 ± 0.09, p < 0.001) and 24 h (1.6 ± 0.05 vs 2.1 ± 0.1, p = 0.05). In conclusion, R. oryzae proliferation was higher among diabetic individuals, including good glycaemic control, than among non-diabetic individuals.


Assuntos
Sangue/microbiologia , Diabetes Mellitus/sangue , Suscetibilidade a Doenças/sangue , Rhizopus/crescimento & desenvolvimento , Esporos Fúngicos/crescimento & desenvolvimento , Adulto , Idoso , Idoso de 80 Anos ou mais , Análise Química do Sangue , Proliferação de Células , Feminino , Germinação , Hemoglobinas Glicadas/análise , Índice Glicêmico , Carga Glicêmica , Humanos , Ferro/sangue , Masculino , Pessoa de Meia-Idade , Mucormicose/metabolismo , Mucormicose/microbiologia
11.
J Clin Invest ; 126(6): 2280-94, 2016 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-27159390

RESUMO

Patients with diabetic ketoacidosis (DKA) are uniquely predisposed to mucormycosis, an angioinvasive fungal infection with high mortality. Previously, we demonstrated that Rhizopus invades the endothelium via binding of fungal CotH proteins to the host receptor GRP78. Here, we report that surface expression of GRP78 is increased in endothelial cells exposed to physiological concentrations of ß-hydroxy butyrate (BHB), glucose, and iron that are similar to those found in DKA patients. Additionally, expression of R. oryzae CotH was increased within hours of incubation with DKA-associated concentrations of BHB, glucose, and iron, augmenting the ability of R. oryzae to invade and subsequently damage endothelial cells in vitro. BHB exposure also increased fungal growth and attenuated R. oryzae neutrophil-mediated damage. Further, mice given BHB developed clinical acidosis and became extremely susceptible to mucormycosis, but not aspergillosis, while sodium bicarbonate reversed this susceptibility. BHB-related acidosis exerted a direct effect on both GRP78 and CotH expression, an effect not seen with lactic acidosis. However, BHB also indirectly compromised the ability of transferrin to chelate iron, as iron chelation combined with sodium bicarbonate completely protected endothelial cells from Rhizopus-mediated invasion and damage. Our results dissect the pathogenesis of mucormycosis during ketoacidosis and reinforce the importance of careful metabolic control of the acidosis to prevent and manage this infection.


Assuntos
Cetoacidose Diabética/tratamento farmacológico , Mucormicose/tratamento farmacológico , Bicarbonato de Sódio/uso terapêutico , Ácido 3-Hidroxibutírico/toxicidade , Animais , Cetoacidose Diabética/complicações , Cetoacidose Diabética/metabolismo , Modelos Animais de Doenças , Chaperona BiP do Retículo Endoplasmático , Células Endoteliais/efeitos dos fármacos , Células Endoteliais/metabolismo , Células Endoteliais/microbiologia , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Glucose/metabolismo , Proteínas de Choque Térmico/genética , Proteínas de Choque Térmico/metabolismo , Interações Hospedeiro-Patógeno/efeitos dos fármacos , Interações Hospedeiro-Patógeno/genética , Interações Hospedeiro-Patógeno/fisiologia , Humanos , Ferro/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos ICR , Mucormicose/etiologia , Mucormicose/metabolismo , Rhizopus/efeitos dos fármacos , Rhizopus/genética , Rhizopus/patogenicidade , Virulência/efeitos dos fármacos
12.
Medicine (Baltimore) ; 95(8): e2933, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26937941

RESUMO

Mucormycosis is an aggressive fungal infection, which invades endothelial cells of blood vessels. This condition might lead to destruction of endothelium and release of heparin-like substances to the bloodstream and cause life-threatening bleeding, which is not well described in the literature.We present a patient with mucormycosis who experienced life-threatening bleeding, although no standard laboratory test could detect any coagulopathy.The cause of bleeding-coagulopathy was detected only by nonactivated thromboelastometry (NATEM), which revealed the presence of heparin-like substances. After treatment with recombinant activated FVII rotational thromboelastometry, results improved and the patient stopped bleeding. Regular application of the drug was necessary during acute phase of infection to prevent further bleeding.In this case report, we show that NATEM can detect the presence of heparin-like substances in bleeding patient with mucormycosis infection and that recombinant activated FVII can be used to stop and prevent bleeding until infection resolves.


Assuntos
Testes de Coagulação Sanguínea , Fator VIIa/uso terapêutico , Hemorragia/terapia , Heparinoides/metabolismo , Mucormicose/tratamento farmacológico , Antifúngicos/uso terapêutico , Criança , Drenagem/efeitos adversos , Feminino , Hemorragia/etiologia , Humanos , Doença Iatrogênica , Mucormicose/metabolismo , Proteínas Recombinantes/uso terapêutico , Baço/lesões , Baço/cirurgia , Esplenectomia
13.
Pathol Res Pract ; 212(5): 393-7, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-26874574

RESUMO

OBJECTIVE: The main aim of our study was to investigate the diagnostic value of a molecular method for the diagnosis of mucormycosis and aspergillosis from formalin-fixed and paraffin-embedded (FFPE) tissues. METHODS: A retrospective chart review identified all cases with histology reports mentioning the presence of fungi with morphological characteristics of either Aspergillus or mucormycetes, for the period 2005-2012. Paraffin blocks were retrieved from the archives of the Department of Pathology. A semi-nested PCR specific for the detection of mucormycetes and Aspergillus species was applied in FFPE tissue from the above blocks. Results were compared with those of histological (gold standard) and microbiological methods. RESULTS: Twenty cases with fungal hyphae in tissue were revealed. Mucormycetes were detected in 9 cases (45%) by PCR, in only 4 of which culture was available. Species of Aspergillus were detected in 8 cases (40%) by PCR, two of which were co-infection with mucormycetes. Five patients had other fungi, non-detectable with this specific PCR. At least one sample per patient was positive by PCR. Seven out of 30 samples tested overall were false negative. The calculated sensitivity of this method in our setting was 79.3% (95% CI: 60.3-91.9%); specificity was 100%. CONCLUSIONS: The specific PCR used appears to be an easy and useful tool for the prompt and accurate diagnosis of mucormycosis and aspergillosis, in combination with histology and direct examination. Mucormycosis was more frequent than aspergillosis during the study period, highlighting the importance of continuous epidemiological surveillance of these serious infections.


Assuntos
Aspergilose/diagnóstico , Mucormicose/diagnóstico , Adulto , Idoso , Idoso de 80 Anos ou mais , Aspergilose/genética , Aspergilose/metabolismo , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mucormicose/genética , Mucormicose/metabolismo , Inclusão em Parafina , Reação em Cadeia da Polimerase/métodos , Estudos Retrospectivos , Sensibilidade e Especificidade
14.
Dis Model Mech ; 8(11): 1375-88, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26398938

RESUMO

Mucormycosis is an emerging fungal infection that is clinically difficult to manage, with increasing incidence and extremely high mortality rates. Individuals with diabetes, suppressed immunity or traumatic injury are at increased risk of developing disease. These individuals often present with defects in phagocytic effector cell function. Research using mammalian models and phagocytic effector cell lines has attempted to decipher the importance of the innate immune system in host defence against mucormycosis. However, these model systems have not been satisfactory for direct analysis of the interaction between innate immune effector cells and infectious sporangiospores in vivo. Here, we report the first real-time in vivo analysis of the early innate immune response to mucormycete infection using a whole-animal zebrafish larval model system. We identified differential host susceptibility, dependent on the site of infection (hindbrain ventricle and swim bladder), as well as differential functions of the two major phagocyte effector cell types in response to viable and non-viable spores. Larval susceptibility to mucormycete spore infection was increased upon immunosuppressant treatment. We showed for the first time that macrophages and neutrophils were readily recruited in vivo to the site of infection in an intact host and that spore phagocytosis can be observed in real-time in vivo. While exploring innate immune effector recruitment dynamics, we discovered the formation of phagocyte clusters in response to fungal spores that potentially play a role in fungal spore dissemination. Spores failed to activate pro-inflammatory gene expression by 6 h post-infection in both infection models. After 24 h, induction of a pro-inflammatory response was observed only in hindbrain ventricle infections. Only a weak pro-inflammatory response was initiated after spore injection into the swim bladder during the same time frame. In the future, the zebrafish larva as a live whole-animal model system will contribute greatly to the study of molecular mechanisms involved in the interaction of the host innate immune system with fungal spores during mucormycosis.


Assuntos
Sacos Aéreos/imunologia , Infecções Fúngicas do Sistema Nervoso Central/imunologia , Imunidade Inata , Mucor/imunologia , Mucormicose/imunologia , Rombencéfalo/imunologia , Peixe-Zebra/imunologia , Sacos Aéreos/efeitos dos fármacos , Sacos Aéreos/embriologia , Sacos Aéreos/metabolismo , Sacos Aéreos/microbiologia , Animais , Infecções Fúngicas do Sistema Nervoso Central/metabolismo , Infecções Fúngicas do Sistema Nervoso Central/microbiologia , Modelos Animais de Doenças , Interações Hospedeiro-Patógeno , Imunidade Inata/efeitos dos fármacos , Imunossupressores/farmacologia , Mediadores da Inflamação/metabolismo , Larva/imunologia , Larva/microbiologia , Macrófagos/imunologia , Macrófagos/microbiologia , Mucor/patogenicidade , Mucormicose/metabolismo , Mucormicose/microbiologia , Neutrófilos/imunologia , Neutrófilos/microbiologia , Fagocitose , Rombencéfalo/efeitos dos fármacos , Rombencéfalo/embriologia , Rombencéfalo/metabolismo , Rombencéfalo/microbiologia , Fatores de Tempo , Peixe-Zebra/embriologia , Peixe-Zebra/metabolismo , Peixe-Zebra/microbiologia
15.
PLoS Pathog ; 9(9): e1003625, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24039585

RESUMO

Many pathogenic fungi are dimorphic and switch between yeast and filamentous states. This switch alters host-microbe interactions and is critical for pathogenicity. However, in zygomycetes, whether dimorphism contributes to virulence is a central unanswered question. The pathogenic zygomycete Mucor circinelloides exhibits hyphal growth in aerobic conditions but switches to multi-budded yeast growth under anaerobic/high CO2 conditions. We found that in the presence of the calcineurin inhibitor FK506, Mucor exhibits exclusively multi-budded yeast growth. We also found that M. circinelloides encodes three calcineurin catalytic A subunits (CnaA, CnaB, and CnaC) and one calcineurin regulatory B subunit (CnbR). Mutations in the latch region of CnbR and in the FKBP12-FK506 binding domain of CnaA result in hyphal growth of Mucor in the presence of FK506. Disruption of the cnbR gene encoding the sole calcineurin B subunit necessary for calcineurin activity yielded mutants locked in permanent yeast phase growth. These findings reveal that the calcineurin pathway plays key roles in the dimorphic transition from yeast to hyphae. The cnbR yeast-locked mutants are less virulent than the wild-type strain in a heterologous host system, providing evidence that hyphae or the yeast-hyphal transition are linked to virulence. Protein kinase A activity (PKA) is elevated during yeast growth under anaerobic conditions, in the presence of FK506, or in the yeast-locked cnbR mutants, suggesting a novel connection between PKA and calcineurin. cnaA mutants lacking the CnaA catalytic subunit are hypersensitive to calcineurin inhibitors, display a hyphal polarity defect, and produce a mixture of yeast and hyphae in aerobic culture. The cnaA mutants also produce spores that are larger than wild-type, and spore size is correlated with virulence potential. Our results demonstrate that the calcineurin pathway orchestrates the yeast-hyphal and spore size dimorphic transitions that contribute to virulence of this common zygomycete fungal pathogen.


Assuntos
Calcineurina/metabolismo , Proteínas Fúngicas/metabolismo , Mucor/enzimologia , Mucor/patogenicidade , Fatores de Virulência/metabolismo , Calcineurina/genética , Linhagem Celular , Proteínas Fúngicas/genética , Humanos , Hifas/enzimologia , Hifas/genética , Hifas/patogenicidade , Imunossupressores/farmacologia , Mucor/genética , Mucormicose/genética , Mucormicose/metabolismo , Mucormicose/patologia , Estrutura Terciária de Proteína , Tacrolimo/farmacologia , Fatores de Virulência/genética
16.
Rev Iberoam Micol ; 30(4): 217-25, 2013.
Artigo em Espanhol | MEDLINE | ID: mdl-23684655

RESUMO

Iron is an essential factor for both the growth and virulence of most of microorganisms. As a part of the innate (or nutritional) immune system, mammals have developed different mechanisms to store and transport this element in order to limit free iron bioavailability. To survive in this hostile environment, pathogenic fungi have specific uptake systems for host iron sources, one of the most important of which is based on the synthesis of siderophores-soluble, low-molecular-mass, high-affinity iron chelators. The increase in free iron that results from iron-overload conditions is a well-established risk factor for invasive fungal infection (IFI) such as mucormycosis or aspergillosis. Therefore, iron chelation may be an appealing therapeutic option for these infections. Nevertheless, deferoxamine -the first approved iron chelator- paradoxically increases the incidence of IFI, as it serves as a xeno-siderophore to Mucorales. On the contrary, the new oral iron chelators (deferiprone and deferasirox) have shown to exert a deleterious effect on fungal growth both in vitro and in animal models. The present review focuses on the role of iron metabolism in the pathogenesis of IFI and summarises the preclinical data, as well as the limited clinical experience so far, in the use of new iron chelators as treatment for mucormycosis and invasive aspergillosis.


Assuntos
Fungemia/metabolismo , Fungos/metabolismo , Ferro/metabolismo , Animais , Antifúngicos/uso terapêutico , Aspergilose/tratamento farmacológico , Aspergilose/metabolismo , Benzoatos/farmacologia , Benzoatos/uso terapêutico , Deferasirox , Deferiprona , Desferroxamina/efeitos adversos , Suscetibilidade a Doenças , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Proteínas Fúngicas/fisiologia , Fungemia/tratamento farmacológico , Fungos/efeitos dos fármacos , Interações Hospedeiro-Patógeno , Humanos , Ferro/farmacocinética , Quelantes de Ferro/efeitos adversos , Quelantes de Ferro/uso terapêutico , Sobrecarga de Ferro/complicações , Sobrecarga de Ferro/metabolismo , Modelos Animais , Estrutura Molecular , Mucorales/efeitos dos fármacos , Mucorales/metabolismo , Mucormicose/tratamento farmacológico , Mucormicose/metabolismo , Oxirredução , Piridonas/farmacologia , Piridonas/uso terapêutico , Sideróforos/fisiologia , Especificidade da Espécie , Relação Estrutura-Atividade , Triazóis/farmacologia , Triazóis/uso terapêutico
18.
Clin Infect Dis ; 54 Suppl 1: S16-22, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22247441

RESUMO

Mucormycosis is a life-threatening infection that occurs in patients who are immunocompromised because of diabetic ketoacidosis, neutropenia, organ transplantation, and/or increased serum levels of available iron. Because of the increasing prevalence of diabetes mellitus, cancer, and organ transplantation, the number of patients at risk for this deadly infection is increasing. Despite aggressive therapy, which includes disfiguring surgical debridement and frequently adjunctive toxic antifungal therapy, the overall mortality rate is high. New strategies to prevent and treat mucormycosis are urgently needed. Understanding the pathogenesis of mucormycosis and the host response to invading hyphae ultimately will provide targets for novel therapeutic interventions. In this supplement, we review the current knowledge about the virulence traits used by the most common etiologic agent of mucormycosis, Rhizopus oryzae. Because patients with elevated serum levels of available iron are uniquely susceptible to mucormycosis and these infections are highly angioinvasive, emphasis is placed on the ability of the organism to acquire iron from the host and on its interactions with endothelial cells lining blood vessels. Several promising therapeutic strategies in preclinical stages are identified.


Assuntos
Ferro/metabolismo , Mucormicose/patologia , Rhizopus/patogenicidade , Cetoacidose Diabética/metabolismo , Cetoacidose Diabética/microbiologia , Células Endoteliais/metabolismo , Células Endoteliais/microbiologia , Genes Fúngicos , Interações Hospedeiro-Patógeno , Humanos , Hospedeiro Imunocomprometido , Mucormicose/metabolismo , Mucormicose/microbiologia , Fagócitos/metabolismo , Fagócitos/patologia , Rhizopus/genética , Rhizopus/metabolismo , Fatores de Risco , Fatores de Virulência/metabolismo
19.
Antimicrob Agents Chemother ; 54(4): 1633-5, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20086161

RESUMO

We report the penetration of liposomal amphotericin B into the pleural fluid of a patient with pulmonary zygomycosis and empyema. The ratio of area under the concentration-versus-time curve in pleural fluid (AUC(pleural fluid)) to that in serum (AUC(serum)) for liposomal amphotericin B over 24 h was 9.4%, with pleural fluid concentrations of 2.12 to 4.91 microg/ml. Given the relatively low level of intrapleural penetration of liposomal amphotericin B, chest tube drainage may be warranted for successful treatment of zygomycotic empyema.


Assuntos
Anfotericina B/farmacocinética , Antifúngicos/farmacocinética , Pneumopatias Fúngicas/tratamento farmacológico , Pneumopatias Fúngicas/metabolismo , Mucormicose/tratamento farmacológico , Mucormicose/metabolismo , Derrame Pleural/metabolismo , Anfotericina B/administração & dosagem , Anfotericina B/sangue , Antifúngicos/administração & dosagem , Antifúngicos/sangue , Empiema Pleural/tratamento farmacológico , Empiema Pleural/metabolismo , Feminino , Humanos , Lipossomos , Pneumopatias Fúngicas/sangue , Pessoa de Meia-Idade , Mucormicose/sangue , Derrame Pleural/tratamento farmacológico
20.
Mycopathologia ; 165(6): 407-10, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18340546

RESUMO

Cunninghamella bertholletiae infection occurs most frequently in neutropenic patients affected by haematological malignancies, is associated with an unfavourable outcome. We report a case of rhino-mastoidal fungal infection in a leukaemic patient. Bioptical tissue cultures yield the isolation of a mould with typical properties of Cunninghamella species. Liposomal amphotericin B (L-Amb) therapy combined with surgical intervention brought the lesion to recovery. Nevertheless, the patient died 14 days after bone marrow transplantation (BMT) from bacterial sepsis. Mastoiditis was documented at CT-scan. The conditioning regimen probably caused the reactivation of the Cunninghamella infection that led to the patient's fatal outcome; fungal hyphae were detected after autopsy of brain and lung tissue.


Assuntos
Anfotericina B/farmacocinética , Transplante de Medula Óssea/efeitos adversos , Cunninghamella/efeitos dos fármacos , Leucemia Mieloide/complicações , Mucormicose/etiologia , Anfotericina B/uso terapêutico , Cunninghamella/patogenicidade , Humanos , Hospedeiro Imunocomprometido , Leucemia Mieloide/tratamento farmacológico , Leucemia Mieloide/metabolismo , Leucemia Mieloide/microbiologia , Leucemia Mieloide/cirurgia , Mucormicose/metabolismo , Infecções Oportunistas/etiologia , Infecções Oportunistas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...